Overview

Ecopipam Tablets to Study Tourette's Syndrome in Children and Adolescents

Status:
Completed
Trial end date:
2021-09-23
Target enrollment:
Participant gender:
Summary
This study evaluates the effect of ecopipam tablets in children and adolescents in the treatment of Tourette's Syndrome (TS). Half of the participants will receive ecopipam tablets, while the other half will receive matching placebo tablets
Phase:
Phase 2
Details
Lead Sponsor:
Emalex Biosciences Inc.
Treatments:
Ecopipam